Hayley Andreasen
Cornerstone
04/30/2015
Medicating Children with ADHD
I. Introduction
a. Attention Getter: Visualize yourself five, ten years down the road.
b. Referto Audience: Some of you may have a child or multiple for that
matter, and some may not. Now imagine one of those children is
diagnosed with ADHD. They are struggling academically, are impulsive,
disruptive, and have low attention span. Unfortunately, you are forced
with the decision to medicate or seek alternative methods of treatment.
c. Main Point: Medication has its perks in masking the symptoms of
ADHD, but alternatives to medicating have a more positive affect over
symptoms without side effects.
d. Establish Credibility: Based on the research I have acquired over the past
two weeks, I feel confident enough to present you with an educated
decision on why medication should not be the first treatment option for
children diagnosed with ADHD.
e. Preview: In the speech I will present information on what the disorder is,
how medicating can affect a young individual, and alternatives that have a
longer lasting affect compared to medication.
Transition: Medicating children with ADHD should be the last treatment
option because the brain is not fully developed, there is a risk of becoming
co-dependent with long-term effects, and there are better alternatives than
medicine.
II. Body
a. What is ADHD and how does it affect the brain?
i. Attention Deficit Hyperactive Disorder is categorized as a
developmental disorder causing a person to become easily
distracted, have a low attention span, hyperactivity, and little to no
impulse control.
ii. The disorder does not usually arise as ADHD alone, but tends to be
co-morbid in nature.
iii. Thanks to imaging studies on the frontal lobes, it is now known the
brain is not fully matured in cognitive processing until the age of
30.
Transition: Because of the struggles the symptoms exhibit in our society
today, medication is looked at as the first treatment option to subdue the
disorder.
b. Medication has become commonplace for the treatment of ADHD
because it controls the symptoms, allows children to focus in the
classroom, but also controls social interactions through the use of a
stimulant.
i. There is evidence to show psychostimulants improve the affected
child’s behavior in both a classroom and social environment.
ii. Stimulants are an easy, efficient way of managing symptoms in
comparison to non-medicated alternatives.
iii. To control the child’s symptomatic actions, psychotropic drugs
tend to be administered. However, young children can be more
sensitive to side effects of the medication.
Transition: Early exposure to these stimulants could have a maladaptive
effect on the child’s developing brain, which could follow them through
adulthood, making non-medicated treatments in the future virtually
impossible.
c. Considering some of these affects, alternatives for using stimulants have
been considered by doctors and parents who are skeptical about
medicating children.
i. By combining drugs with therapy, there is a greater chance of
diminishing the majority of the problematic symptoms the disorder
presents.
ii. The range of factors able to contribute to the development of the
disorder, as well as, the gene expressed ADHD can often be treated
without the use of stimulant medication.
iii. Because there is a wide array of causes for the disorder there is a
wide range of non-medical treatments that can help treat the
symptoms.
Transition: Finding the right treatment options for children with ADHD
is a decision every parent and doctor need to consider before jumping into
the use of stimulant medication.
III. Conclusion
a. Restate thesis: Although the symptoms of attention deficit hyperactive
disorder may cause many problems in structured environments, our
society is more concerned about masking the disorder rather than finding
ways to manage the symptoms effectively.
b. Referto audience: Knowing what you know now, would you medicate or
seek alternatives if your future child developed ADHD?
c. Review main points: Stimulants therefore, have been the primary
treatment option with little thought given to other alternatives. However,
the possible long-term side effects stimulants offer may not be worth the
risk for children.
d. Clincher: How would you decide?
References
1. Edwards, D. L., & K. P. (2001). Adlerian School-Based Interventions for
Children with Attention-Deficit/Hyperactivity Disorder. Journal of Individual
Psychology, 57(3), 210.
2. Daley, D., Jones, K., Hutchings, J., & Thompson, M. (2009). Attention deficit
hyperactivity disorder in pre-school children: current findings, recommended
interventions and future directions. Child: Care, Health & Development, 35(6),
754-766.
3. Pellow, J., Solomon, E. M., & Barnard, C. N. (2011). Complementary and
Alternative Medical Therapies for Children with Attention-Deficit/Hyperactivity
Disorder (ADHD). Alternative Medicine Review, 16(4), 323-337.
4. Foltz, R. (2010). Medicating Our Youth: Who Determines Rules of Evidence?.
Reclaiming Children & Youth, 19(2), 10-15.
5. Pringsheim, T., Hirsch, L., Gardner, D., & Gorman, D. A. (2015). The
Pharmacological Management of Oppositional Behaviour, Conduct Problems, and
Aggression in Children and Adolescents with Attention-Deficit Hyperactivity
Disorder, Oppositional Defiant Disorder, and Conduct Disorder: A Systematic
Review and Canadian Journal of Psychiatry, 60(2), 42-51.
6. Brackenridge, R., McKenzie, K., Murray, G. C., & Quigley, A. (2011). An
examination of the effects of stimulant medication on response inhibition: A
comparison between children with and without attention deficit hyperactivity
disorder. Research In Developmental Disabilities, 322797-2804.
7. Kluger, J., Cray, D., Daly, M., Myers, R., Park, A., Klarreich, K., & Whitaker, L.
(2004). MEDICATING YOUNG MINDS. Time International (Canada Edition),
163(3), 38.
8. Garfield, L. D., Brown, D. S., Allaire, B. T., Ross, R. E., Nicol, G. E., &
Raghavan, R. (2015). Psychotropic Drug Use Among Preschool Children in the
Medicaid Program From 36 States. American Journal Of Public Health, 105(3),
524-529.

Medicating Outline

  • 1.
    Hayley Andreasen Cornerstone 04/30/2015 Medicating Childrenwith ADHD I. Introduction a. Attention Getter: Visualize yourself five, ten years down the road. b. Referto Audience: Some of you may have a child or multiple for that matter, and some may not. Now imagine one of those children is diagnosed with ADHD. They are struggling academically, are impulsive, disruptive, and have low attention span. Unfortunately, you are forced with the decision to medicate or seek alternative methods of treatment. c. Main Point: Medication has its perks in masking the symptoms of ADHD, but alternatives to medicating have a more positive affect over symptoms without side effects. d. Establish Credibility: Based on the research I have acquired over the past two weeks, I feel confident enough to present you with an educated decision on why medication should not be the first treatment option for children diagnosed with ADHD. e. Preview: In the speech I will present information on what the disorder is, how medicating can affect a young individual, and alternatives that have a longer lasting affect compared to medication. Transition: Medicating children with ADHD should be the last treatment option because the brain is not fully developed, there is a risk of becoming co-dependent with long-term effects, and there are better alternatives than medicine. II. Body a. What is ADHD and how does it affect the brain? i. Attention Deficit Hyperactive Disorder is categorized as a developmental disorder causing a person to become easily distracted, have a low attention span, hyperactivity, and little to no impulse control. ii. The disorder does not usually arise as ADHD alone, but tends to be co-morbid in nature. iii. Thanks to imaging studies on the frontal lobes, it is now known the brain is not fully matured in cognitive processing until the age of 30. Transition: Because of the struggles the symptoms exhibit in our society today, medication is looked at as the first treatment option to subdue the disorder. b. Medication has become commonplace for the treatment of ADHD because it controls the symptoms, allows children to focus in the classroom, but also controls social interactions through the use of a stimulant.
  • 2.
    i. There isevidence to show psychostimulants improve the affected child’s behavior in both a classroom and social environment. ii. Stimulants are an easy, efficient way of managing symptoms in comparison to non-medicated alternatives. iii. To control the child’s symptomatic actions, psychotropic drugs tend to be administered. However, young children can be more sensitive to side effects of the medication. Transition: Early exposure to these stimulants could have a maladaptive effect on the child’s developing brain, which could follow them through adulthood, making non-medicated treatments in the future virtually impossible. c. Considering some of these affects, alternatives for using stimulants have been considered by doctors and parents who are skeptical about medicating children. i. By combining drugs with therapy, there is a greater chance of diminishing the majority of the problematic symptoms the disorder presents. ii. The range of factors able to contribute to the development of the disorder, as well as, the gene expressed ADHD can often be treated without the use of stimulant medication. iii. Because there is a wide array of causes for the disorder there is a wide range of non-medical treatments that can help treat the symptoms. Transition: Finding the right treatment options for children with ADHD is a decision every parent and doctor need to consider before jumping into the use of stimulant medication. III. Conclusion a. Restate thesis: Although the symptoms of attention deficit hyperactive disorder may cause many problems in structured environments, our society is more concerned about masking the disorder rather than finding ways to manage the symptoms effectively. b. Referto audience: Knowing what you know now, would you medicate or seek alternatives if your future child developed ADHD? c. Review main points: Stimulants therefore, have been the primary treatment option with little thought given to other alternatives. However, the possible long-term side effects stimulants offer may not be worth the risk for children. d. Clincher: How would you decide? References 1. Edwards, D. L., & K. P. (2001). Adlerian School-Based Interventions for Children with Attention-Deficit/Hyperactivity Disorder. Journal of Individual Psychology, 57(3), 210.
  • 3.
    2. Daley, D.,Jones, K., Hutchings, J., & Thompson, M. (2009). Attention deficit hyperactivity disorder in pre-school children: current findings, recommended interventions and future directions. Child: Care, Health & Development, 35(6), 754-766. 3. Pellow, J., Solomon, E. M., & Barnard, C. N. (2011). Complementary and Alternative Medical Therapies for Children with Attention-Deficit/Hyperactivity Disorder (ADHD). Alternative Medicine Review, 16(4), 323-337. 4. Foltz, R. (2010). Medicating Our Youth: Who Determines Rules of Evidence?. Reclaiming Children & Youth, 19(2), 10-15. 5. Pringsheim, T., Hirsch, L., Gardner, D., & Gorman, D. A. (2015). The Pharmacological Management of Oppositional Behaviour, Conduct Problems, and Aggression in Children and Adolescents with Attention-Deficit Hyperactivity Disorder, Oppositional Defiant Disorder, and Conduct Disorder: A Systematic Review and Canadian Journal of Psychiatry, 60(2), 42-51. 6. Brackenridge, R., McKenzie, K., Murray, G. C., & Quigley, A. (2011). An examination of the effects of stimulant medication on response inhibition: A comparison between children with and without attention deficit hyperactivity disorder. Research In Developmental Disabilities, 322797-2804. 7. Kluger, J., Cray, D., Daly, M., Myers, R., Park, A., Klarreich, K., & Whitaker, L. (2004). MEDICATING YOUNG MINDS. Time International (Canada Edition), 163(3), 38. 8. Garfield, L. D., Brown, D. S., Allaire, B. T., Ross, R. E., Nicol, G. E., & Raghavan, R. (2015). Psychotropic Drug Use Among Preschool Children in the Medicaid Program From 36 States. American Journal Of Public Health, 105(3), 524-529.